Maintenance of High Levels of Viral Suppression and Improved Safety Profile of Tenofovir Alafenamide (Taf) Relative to Tenofovir Disoproxil Fumarate (Tdf) in Chronic Hepatitis B Patients Treated for 5 Years in 2 Ongoing Phase 3 Studies
Journal article published in 2020 by
Henry Lik Yuen Chan,
Maria Asuncion Buti Ferret,
Kosh Agarwal 
,
Patrick Marcellin,
Young-Suk Lim,
Maurizia R. Brunetto,
Wan-Long Chuang,
Harry L. A. Janssen,
Scott K. Fung,
Namiki Izumi,
John F. Flaherty,
Vithika Suri,
Bing Gao,
Gregory Camus,
Anuj Gaggar
and other authors.
,
Patrick Marcellin,
Young-Suk Lim,
Maurizia R. Brunetto,
Wan-Long Chuang,
Harry L. A. Janssen,
Scott K. Fung,
Namiki Izumi,
John F. Flaherty,
Vithika Suri,
Bing Gao,
Gregory Camus,
Anuj Gaggar
and other authors.
